Together with mentor Ranga Yogeshwar, TOP 100 honors the most innovative companies in the German SME sector for the 29th time. We convinced the jury around Prof. Dr. Nikolaus Franke as a think tank in the scientific selection process.

Until now, RhD-negative pregnant women were generally advised to take rhesus prophylaxis. Now, thanks to our new FastQ^® RHD fetal, targeted anti-D prophylaxis is possible by using modern non-invasive molecular fetal diagnostics via real-time PCR typing.

Reliably typing even more variants of the corona virus SARS-CoV-2! With the new differentiation kit ViroQ^® SC2 Variant 2, even more deviations from the virus of origin can be reliably detected.

Innovation in virological infectiology: The new real-time rapid test ViroQ SARS-FluA/B-RSV. The new test reliably detectss with just one PCR run SARS-CoV-2, RS, Influenza A and B viruses.

With our new distribution partner Sysmex America, Inc. the PCR rapid test for the safe detection of SARS CoV-2 is now also available in the USA and Canada. FDA EUA certification has already been submitted.

BAG Diagnostics has developed a rapid test that transcribes and amplifies the RNA from SARS-CoV-2 to cDNA in a one-step PCR procedure. The kit is the first test to check whether there is enough cell material in the sample smear to produce a valid negative result.